ORAMED PHARMACEUTICALS INC. (ORMP) Operating income 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual operating income history from SEC filings — each fiscal year as reported.
-$15.1MFY2025 · since FY2016: -$10.0M → -$15.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.1M | -18.1% |
| FY2024 | -$12.8M | +18.9% |
| FY2023 | -$15.8M | +61.2% |
| FY2022 | -$40.6M | -67.6% |
| FY2021 | -$24.2M | -106.0% |
| FY2020 | -$11.8M | +19.6% |
| FY2019 | -$14.6M | -8.2% |
| FY2018 | -$13.5M | -25.6% |
| FY2017 | -$10.8M | -7.6% |
| FY2016 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice